Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / FRLN - Freeline Therapeutics GAAP EPS of -$1.15


FRLN - Freeline Therapeutics GAAP EPS of -$1.15

  • Freeline Therapeutics press release ( NASDAQ: FRLN ): 9M GAAP EPS of -$1.15.
  • Unrestricted cash and cash equivalents were $65.8 million as of September 30, 2022, compared to $117.7 million as of December 31, 2021. With the changes announced today, Freeline now expects that its current level of cash and cash equivalents, plus the anticipated proceeds from the sale of Freeline Therapeutics GmbH, will enable the company to fund its planned operations into 2024.

For further details see:

Freeline Therapeutics GAAP EPS of -$1.15
Stock Information

Company Name: Freeline Therapeutics Holdings plc
Stock Symbol: FRLN
Market: NASDAQ
Website: freeline.life

Menu

FRLN FRLN Quote FRLN Short FRLN News FRLN Articles FRLN Message Board
Get FRLN Alerts

News, Short Squeeze, Breakout and More Instantly...